Thymosin Alpha-1

Thymosin Alpha-1 is a peptide naturally produced by the thymus gland that plays a crucial role in immune system modulation. It is approved in over 35 countries for various conditions including hepatitis B and C.

Mechanism of Action

Enhances T-cell function and maturation, stimulates dendritic cell activity, and modulates cytokine production. Promotes the differentiation of stem cells into mature T lymphocytes.

Typical Dosage (Research)

Clinical dosing typically ranges from 1.6mg to 6.4mg administered subcutaneously 2-3 times weekly. Research protocols may vary.

Subcutaneous injection. Often used in cycles or as part of comprehensive immune support protocols.

Side Effects & Risks

Generally well-tolerated. Rare side effects include injection site reactions, mild flu-like symptoms, and temporary fatigue.

Should be used cautiously in autoimmune conditions. May interact with immunosuppressive medications. Consult healthcare provider before use.

Who Uses Thymosin Alpha-1

Those seeking immune system support, individuals with chronic infections, cancer patients (under medical supervision), biohackers focused on longevity.